Insider Trading activities of Genocea Biosciences, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genocea Biosciences, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genocea Biosciences, Inc. since year 2005. Table 2 shows the detailed insider transactions of Genocea Biosciences, Inc. since 2005. The reporting company's ticker symbol is GNCA. The reporting company's CIK number is 1457612.
The total value of stock buying since 2005 is $18,244,168.
The total value of stock sales since 2005 is $3,008,375.
The total value of stock option exercises since 2005 is $570,452.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Genocea Biosciences, Inc. (GNCA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-07 0 $0 45,000 $270,000 45,000 $139,050
2017-05 53,332 $322,172 6,213 $40,446 53,332 $124,920
2016-11 16,800 $57,562 0 $0 5,000 $10,100
2016-05 4,000 $15,520 0 $0 0 $0
2015-12 3,800 $24,510 0 $0 13,906 $28,090
2015-09 0 $0 2,229 $25,299 2,229 $4,502
2015-08 0 $0 2,229 $29,088 7,229 $14,602
2015-07 0 $0 2,229 $31,027 2,229 $4,502
2015-06 0 $0 88,851 $1,161,841 2,229 $4,502
2015-05 0 $0 2,229 $22,758 2,229 $4,502
2015-04 0 $0 2,283 $26,870 2,283 $6,529
2015-03 700,000 $5,775,000 3,754 $31,909 3,754 $9,835
2015-02 0 $0 3,085 $26,222 3,085 $7,342
2015-01 0 $0 1,614 $13,719 1,614 $3,841
2014-12 0 $0 0 $0 19,807 $56,648
2014-09 0 $0 22,163 $271,778 43,843 $109,935
2014-08 0 $0 80,214 $1,057,418 17,760 $41,552
2014-02 1,004,117 $12,049,404 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Genocea Biosciences, Inc. insiders (GNCA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-07-24 Poole Jonathan (Chief Financial Officer) Sale 45,000 6.00 270,000
2017-07-24 Poole Jonathan (Chief Financial Officer) Option Ex 45,000 3.09 139,050
2017-05-19 Siber George Buy 22,287 6.07 135,282
2017-05-19 Siber George Option Ex 22,287 2.62 58,391
2017-05-18 Siber George Buy 31,045 6.02 186,890
2017-05-18 Siber George Option Ex 31,045 2.14 66,529
2017-05-08 Poole Jonathan (Chief Financial Officer) Sale 6,213 6.51 40,446
2016-11-09 Hetherington Seth V (Chief Medical Officer) Option Ex 5,000 2.02 10,100
2016-11-08 Hoffman Eric S (Chief Business Officer) Buy 3,000 3.59 10,770
2016-11-07 Hoffman Eric S (Chief Business Officer) Buy 4,000 3.41 13,640
2016-11-07 Poole Jonathan (Chief Financial Officer) Buy 7,000 3.34 23,380
2016-11-07 Clark William D (President and CEO) Buy 2,800 3.49 9,772
2016-05-09 Poole Jonathan (Chief Financial Officer) Buy 4,000 3.88 15,520
2015-12-16 Clark William D (President and CEO) Buy 3,800 6.45 24,510
2015-12-14 Flechtner Jessica Baker (VP of Research) Option Ex 8,906 2.02 17,990
2015-12-11 Hetherington Seth V (Chief Medical Officer) Option Ex 5,000 2.02 10,100
2015-09-01 Flechtner Jessica Baker (Sr. VP of Research) Sale 2,229 11.35 25,299
2015-09-01 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 2,229 2.02 4,502
2015-08-07 Hetherington Seth V (Chief Medical Officer) Option Ex 5,000 2.02 10,100
2015-08-03 Flechtner Jessica Baker (Sr. VP of Research) Sale 2,229 13.05 29,088
2015-08-03 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 2,229 2.02 4,502
2015-07-01 Flechtner Jessica Baker (Sr. VP of Research) Sale 2,229 13.92 31,027
2015-07-01 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 2,229 2.02 4,502
2015-06-19 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 1,000 13.00 13,000
2015-06-18 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 29,004 13.04 378,212
2015-06-17 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 10,618 13.01 138,140
2015-06-16 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 46,000 13.24 609,040
2015-06-01 Flechtner Jessica Baker (Sr. VP of Research) Sale 2,229 10.52 23,449
2015-06-01 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 2,229 2.02 4,502
2015-05-01 Flechtner Jessica Baker (Sr. VP of Research) Sale 2,229 10.21 22,758
2015-05-01 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 2,229 2.02 4,502
2015-04-01 Flechtner Jessica Baker (Sr. VP of Research) Sale 2,283 11.77 26,870
2015-04-01 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 2,283 2.86 6,529
2015-03-17 Hoffman Stephen J (Director) Buy 700,000 8.25 5,775,000
2015-03-02 Flechtner Jessica Baker (Sr. VP of Research) Sale 3,754 8.50 31,909
2015-03-02 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 3,754 2.62 9,835
2015-02-02 Flechtner Jessica Baker (Sr. VP of Research) Sale 3,085 8.50 26,222
2015-02-02 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 3,085 2.38 7,342
2015-01-29 Flechtner Jessica Baker (Sr. VP of Research) Sale 1,614 8.50 13,719
2015-01-29 Flechtner Jessica Baker (Sr. VP of Research) Option Ex 1,614 2.38 3,841
2014-12-12 Clark William D (President and CEO) Option Ex 19,807 2.86 56,648
2014-09-12 Flechtner Jessica Baker (VP of Research) Sale 1,932 12.00 23,184
2014-09-12 Flechtner Jessica Baker (VP of Research) Option Ex 3,612 2.02 7,314
2014-09-11 Giannasca Paul (VP of Development) Sale 4,071 11.84 48,200
2014-09-11 Giannasca Paul (VP of Development) Option Ex 4,071 2.02 8,223
2014-09-11 Flechtner Jessica Baker (VP of Research) Sale 4,503 12.00 54,036
2014-09-11 Flechtner Jessica Baker (VP of Research) Option Ex 4,503 2.02 9,118
2014-09-10 Giannasca Paul (VP of Development) Sale 834 12.35 10,299
2014-09-10 Giannasca Paul (VP of Development) Option Ex 834 2.02 1,684
2014-09-09 Giannasca Paul (VP of Development) Sale 2,455 12.43 30,515
2014-09-09 Giannasca Paul (VP of Development) Option Ex 2,455 2.02 4,959
2014-09-08 Giannasca Paul (VP of Development) Sale 2,970 12.80 38,016
2014-09-08 Giannasca Paul (VP of Development) Option Ex 2,970 2.02 5,999
2014-09-02 Giannasca Paul (VP of Development) Sale 5,398 12.51 67,528
2014-09-02 Giannasca Paul (VP of Development) Option Ex 5,398 2.86 15,438
2014-09-02 Clark William D (President and CEO) Option Ex 20,000 2.86 57,200
2014-08-29 Giannasca Paul (VP of Development) Sale 855 12.86 10,995
2014-08-29 Giannasca Paul (VP of Development) Option Ex 855 2.86 2,445
2014-08-28 Giannasca Paul (VP of Development) Sale 4,602 12.36 56,880
2014-08-28 Giannasca Paul (VP of Development) Option Ex 4,602 2.86 13,161
2014-08-27 Giannasca Paul (VP of Development) Sale 1,303 12.77 16,639
2014-08-27 Giannasca Paul (VP of Development) Option Ex 1,303 2.86 3,726
2014-08-18 Hetherington Seth V (Chief Medical Officer) Option Ex 11,000 2.02 22,220
2014-08-14 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 6,755 13.01 87,882
2014-08-13 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 2,905 13.00 37,765
2014-08-12 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 20,990 13.03 273,499
2014-08-11 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 1,428 13.24 18,906
2014-08-08 Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) Sale 41,376 13.41 554,852
2014-02-10 George Simeon Buy 143,773 12.00 1,725,276
2014-02-10 Bitterman Kevin Buy 232,820 12.00 2,793,840
2014-02-10 Polaris Venture Partners V, L.p. Buy 232,820 12.00 2,793,840
2014-02-10 Hoffman Stephen J Buy 250,931 12.00 3,011,172
2014-02-10 Glaxosmithkline Plc Buy 143,773 12.00 1,725,276

Insider trading activities including stock purchases, stock sales, and option exercises of GNCA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genocea Biosciences, Inc. (symbol GNCA, CIK number 1457612) see the Securities and Exchange Commission (SEC) website.